C26.1 Malignant neoplasm of spleen

Name of the Condition

• Malignant neoplasm of spleen

Summary

This condition refers to a cancerous tumor originating in the spleen. It is classified as a primary splenic malignancy, distinct from cancers that spread to the spleen from other sites. The spleen is part of the lymphatic system and plays a role in filtering blood and supporting immune function.

Causes

The exact cause of splenic malignancies is often unknown, but they typically arise from genetic mutations leading to uncontrolled cell growth in splenic tissue. Contributing factors may include chronic inflammation, exposure to carcinogens, and underlying genetic predispositions.

Risk Factors

• Family history of lymphatic or splenic cancers
• Chronic inflammatory conditions (e.g., autoimmune disorders)
• Prior radiation exposure to the abdomen
• Certain hereditary syndromes (e.g., Li-Fraumeni syndrome)
• Age (over 60)
• Immunodeficiency disorders

Symptoms

Symptoms may include abdominal pain or fullness (especially on the left side), unexplained weight loss, fatigue, fever, night sweats, or anemia. Some cases may be asymptomatic and detected incidentally during imaging for other conditions.

Diagnosis

Diagnosis involves imaging (CT, MRI, or PET scans) to assess the spleen and surrounding structures, followed by biopsy (often via fine-needle aspiration or surgical sampling) for histopathologic examination. Blood tests may also evaluate for abnormal cell counts or markers.

Treatment Options

Treatment depends on the tumor type, stage, and overall health. Options may include surgery (splenectomy), chemotherapy, radiation therapy, or targeted therapies. Immunotherapy or clinical trials may be considered for certain cases.

Prognosis and Follow-Up

Prognosis varies based on the cancer type, stage at diagnosis, and response to treatment. Regular follow-up with imaging and blood tests is typically recommended to monitor for recurrence or complications. Long-term outcomes depend on individual factors and treatment effectiveness.

Complications

Potential complications include rupture of the spleen (risk of hemorrhage), spread to other organs (metastasis), infection due to reduced immune function, or anemia from impaired blood filtration. Treatment-related side effects (e.g., from chemotherapy) may also occur.

Lifestyle & Prevention

While specific prevention strategies are limited, maintaining a healthy lifestyle (balanced diet, regular exercise, avoiding tobacco/alcohol) may support overall health. Managing underlying conditions (e.g., chronic inflammation) and adhering to recommended screenings (if at high risk) can aid early detection.

When to Seek Professional Help

Seek medical attention for persistent abdominal pain, unexplained weight loss, fever, or signs of infection. Prompt evaluation is important if symptoms worsen or new symptoms develop, especially in individuals with known risk factors.

Tips for Medical Coders

Document the specific histologic type (e.g., lymphoma, sarcoma) and any relevant details (e.g., metastasis, treatment) to support accurate coding. Ensure the diagnosis aligns with clinical findings and imaging results. Verify that the code C26.1 is appropriate for primary splenic malignancies, excluding secondary spread from other sites.